Eterna Therapeutics Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Eterna Therapeutics Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Eterna Therapeutics Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $120K, a 91.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $120K -$1.25M -91.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $120K -$1.12M -90.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $120K -$1.01M -89.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $4.05M +$3.23M +394% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.37M Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.24M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.13M +$646K +132% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $819K Sep 30, 2022 10-Q 2022-11-14
Q4 2021 $488K +$438K +876% Dec 31, 2021 10-K 2023-03-20
Q4 2020 $50K -$47K -48.5% Dec 31, 2020 10-K 2021-03-11
Q3 2020 $62K -$38K -38% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $62K -$38K -38% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $120K +$20K +20% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 $97K -$6K -5.83% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $100K +$16K +19% Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $100K +$71K +245% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $100K +$66K +194% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $103K +$87K +544% Dec 31, 2018 10-K 2020-03-19
Q3 2018 $84K -$3K -3.45% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $29K -$71K -71% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $34K -$76K -69.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $16K -$76K -82.6% Dec 31, 2017 10-K 2019-03-22
Q3 2017 $87K -$13K -13% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $100K -$2K -1.96% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $110K -$9K -7.56% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $92K -$32K -25.8% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $100K -$33K -24.8% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $102K -$47K -31.5% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $119K +$62K +109% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $124K +$67K +118% Dec 31, 2015 10-K 2017-03-09
Q3 2015 $133K +$47K +54.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $149K +$65K +77.4% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $57K -$28K -32.9% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $57K -$27K -32.1% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $86K -$224K -72.3% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $84K -$223K -72.6% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $85K -$213K -71.5% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $84K -$136K -61.8% Dec 31, 2013 10-K 2015-03-27
Q3 2013 $310K +$257K +485% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $307K +$248K +420% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $298K +$234K +366% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 $220K +$159K +261% Dec 31, 2012 10-K 2014-03-31
Q3 2012 $53K -$36K -40.4% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $59K -$30K -33.7% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $64K Mar 31, 2012 10-Q 2012-05-11
Q4 2011 $61K +$20K +48.8% Dec 31, 2011 10-K 2013-03-29
Q3 2011 $89K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $89K Jun 30, 2011 10-Q 2011-08-12
Q4 2010 $41K Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.